Recall Z-2498-2021
Roche Molecular Systems, Inc. · initiated August 4, 2021
Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature
Product
cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas Liat System, Catalog Number 09211101190
Codes / lots: Lot 10119Z
Reason for recall
Customers have reported an increased number of false positive SARS-CoV-2 results.
FDA-determined cause: Under Investigation by firm
Action taken
On August 4, 2021, the firm issued Urgent Medical Device Correction letters to affected customers. Customers were instructed to take the following actions: - Immediately discontinue the use of the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas Liat system, lot number 10119Z. - For handling previous positive results generated with the cobas SARS-CoV-2 & Influenza A/B test for use on the cobas Liat system, follow your laboratory s standard operating procedures to investigate the potential for false positive results. Please consult with the physician or clinicians at your facility to determine specific clinical implications for your patients. - Repeat testing can be performed using other cobas SARS-CoV-2 & Influenza A/B lot numbers. - Complete all sections of the enclosed faxback form and fax it to 1-888-312-5960 or email it to Roche4691@stericycle.com. - Discard lot number 10119Z according to your local waste management ordinance. - File this Urgent Medical Device Correction (UMDC) for future reference. Please contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week at 1-800-800-5973 if you have questions about this recall.
Details
- Recall number
- Z-2498-2021
- Initiated
- August 4, 2021
- Terminated
- February 23, 2024
- Product code
- QLT – Covid-19 Multi-Analyte Respiratory Panel Nucleic Acid Devices
- Quantity
- 211 kits (US); 3073 kits (OUS)
- Distribution
- Worldwide distribution - US Nationwide distribution in the states of AR, CA, IL, IN, KS, ME, MI, MN, MO, NY, OR, TN, TX, WA, and WI. The countries of Canada, UK, Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Netherlands, Norway, Poland, Slovakia, and Spain.
- Recalling firm
- Roche Molecular Systems, Inc., S Branchburg, NJ